Possible genetically determined mechanisms of arterial hypertension in tobacco smoking
| Autor: | N. A. Bichan, A. C. Rublevskaya, A. Sh. Smirnova, N. V. Maltseva |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Candidate gene Pregnancy biology business.industry 030204 cardiovascular system & hematology medicine.disease biology.organism_classification Bioinformatics Nitric oxide 03 medical and health sciences chemistry.chemical_compound Therapeutic approach 030104 developmental biology 0302 clinical medicine Pharmacotherapy chemistry Enos Polymorphism (computer science) medicine Endothelial dysfunction Cardiology and Cardiovascular Medicine business |
| Zdroj: | Kardiologiia. 59:4-10 |
| ISSN: | 2412-5660 0022-9040 |
| DOI: | 10.18087/cardio.2556 |
| Popis: | Te increase in the prevalence of arterial hypertension (AH) in populations, ineffective treatment, the need for risk stratifcation, prevention, early diagnosis and successful treatment, actualize genomic studies to develop a personalized therapeutic approach to AH. Te review investigates the possible genetically determined mechanisms of the development of hypertension and endothelial dysfunction caused by polymorphism of the genes of endothelial nitric oxide synthase (eNOS) and enzymes of phases I and II of the xenobiotics detoxifcation system. Te probable interaction of both systems under the influence of harmful environmental factors, including tobacco smoking, and in the gestational period is discussed. It is proposed to study AH candidate genes in the xenobiotics detoxifcation system, the carriage of different variants of which can determine the sensitivity or resistance to antihypertensive pharmacotherapy, which can be useful for developing of the personalized tactics of managing patients with AH. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|